"We have invented a molecule in Manitoba. We are friendly Manitobans. And we will extend this friendliness globally."
Nitesh Sanghai became a friendly Manitoban in 2018 when he moved to Winnipeg from India to work under Dr. Geoffrey K. Tranmer as a post-doctoral candidate at University of Manitoba. Dr. Tranmer posed a tough challenge: synthesize a new molecule to help treat ALS. Nitesh hadn't heard of ALS, but inspired by his late father's words to "do something new," Nitesh hit the ground running. 6 months later, Borsantrazole™ was born.
Join us in this season finale of originALS: more than ALS as Nitesh tells us the story of Borsantrazole™, a story where passion, community, and mutual empowerment drive a narrative of triumph for the ALS community. We discuss the evidence that shows Borsantrazole™ has the potential to improve quality of life and extend life for ALS patients, the battle to manage expectations in the promising pre-clinical stage, and the funding needed to take Borsantrazole™ from bench to bedside.
Later, Nitesh shares his long and strenuous journey to become a first generation scientist, motivated by support from his father, Jay, and wife, Bhavna. Stick around to the end to hear some tidbits from Bhavna and Nitesh's eldest daughter, Parin!
To read Nitesh's thesis paper, click here.
For more information on Borotherapeutics Ltd., visit https://borotherapeutics.com/.
To read My Amyotrophic Lateral Sclerosis Journey (ALS) from weakness to diagnosis: A Journey of Hope, click here.
And for more information on ALS, visit ALS Canada at https://als.ca/.
If you'd like to share your story on the show, or have ideas for what you'd like to hear us speak about next, send us an email at originals.morethanals@gmail.com. We'd love to hear from you!
